About 253 results

ALLMedicine™ Cystic Hygroma Center

Research & Reviews  93 results

Retrospective analysis of genetic etiology and obstetric outcome of fetal cystic hygrom...
Medicine Cai M, Guo N et. al.

Dec 2nd, 2022 - Cystic hygroma (CH) is a relatively common observation in prenatal ultrasounds; however, there are few studies about copy number variations (CNVs) of fetuses with CH. We performed a retrospective analysis on 40 pregnant patients (out of 8000 pregn...

OK-432 Sclerotherapy of Giant Cervicomediastinal Cystic Hygroma.
The Journal of Craniofacial Surgery; Wang S, Li X et. al.

Nov 22nd, 2022 - Cystic hygroma is one type of the benign malformations and typically located in the neck, clavicle, and others, in children under the age of 5 years. However, the incidence of giant cervicomediastinal giant cystic hygroma is very rare, especially ...

Whole exome sequencing, clinical exome or targeted gene panels: what to choose for susp...
BMJ Case Reports; Das S, Sharma C et. al.

Sep 20th, 2022 - Lethal skeletal dysplasias (SDs) are a heterogeneous group of rare but important genetic disorders characterised by abnormal growth and development of bone and cartilage. The phenotypic variation of SD highlights the complex aetiology for this gro...

Prenatal diagnosis of cystic hygroma cases in a tertiary centre and retrospective analy...
Journal of Obstetrics and Gynaecology : the Journal of Th... Demir SS, Cagliyan E et. al.

Aug 26th, 2022 - The aim of this study is to retrospectively examine invasive diagnostic methods, structural anomalies accompanying cystic hygroma, and pregnancy outcomes in cystic hygroma cases admitted to a tertiary centre. The population of the study consisted ...

Retrospective analysis of 2054 cases from 24 hospitals underwent ultrasonic consultatio...
Journal of Clinical Ultrasound : JCU; Wang J, Han J et. al.

Jul 30th, 2022 - To investigate the practices of prenatal ultrasound consultation in a region of the China and to describe the rate of concordance between the suspected anomaly and the final diagnosis of the referral examination. Retrospective study with all cases...

see more →

Clinicaltrials.gov  1 results

Hydrops: Diagnosing & Redefining Outcomes With Precision Study

Oct 4th, 2021 - Up to 1:1700 pregnancies are affected by non-immune hydrops fetalis (NIHF), and this condition is associated with significant perinatal risks ranging from preterm birth to Ballantyne (maternal mirror) syndrome, stillbirth, and neonatal death. Birt...

see more →

News  6 results

New Face Freezer; Opioid Scripts Down but Deaths Up; Violent Deaths and Pregnancy

Sep 9th, 2022 - Note that some links may require subscriptions. The FDA approved injectable daaxibotulinumtoxinA-lanm (Daxxify) -- the first and only peptide-formulated neuromodulator -- for the temporary improvement of moderate to severe frown lines in adults, R...

Lesions on the Thigh After an Organ Transplant
Tina Hsu, MD, Patrick S. Phelan, MD, MPHS et. al.

Sep 7th, 2021 - The Diagnosis: Microcystic Lymphatic Malformation The shave biopsy demonstrated numerous thin-walled vascular spaces filled with lymphatic fluid within the dermis (Figure), consistent with a diagnosis of microcystic lymphatic malformation (LM). Ly.

2021 Update on sequencing in prenatal genetics
Rebecca Reimers, MD, Stephanie Guseh, MD

Apr 12th, 2021 - Prenatal diagnosis has expanded from identification of aneuploidy to include copy number variants detected on microarray (such as 22q11 deletion syndrome) and now single-gene disorders identified by targeted or exome and genome sequencing. How and.

Highlights of the Society of Maternal-Fetal Medicine 25th Annual Clinical Meeting

Mar 11th, 2005 - FASTER Trial and Prenatal Screening for Aneuploidies A number of abstracts presented at the meeting were based on the database developed as a part of the First and Second Trimester Evaluation of Risk (FASTER) trial. Presented at the SMFM meeting i...

Highlights From the Annual Clinical Genetics Meeting

Apr 7th, 2003 - Update From the FASTER Trial The First and Second Trimester Evaluation of Risk (FASTER) trial is an ongoing study being conducted by Dr. Mary D'Alton, Chairman of the Department of Obstetrics and Gynecology at Columbia University in New York City....

see more →

Patient Education  1 results see all →